Schmidt C, Scheubeck G, Jurinovic V, Sokler M, et al. Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance. Haematologica 2025 Jun 12. doi: 10.3324/haematol.2024.287162.
PMID: 40501414